Clinical Trial Update: A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer [Phase 1]

View source ↗

Summary

An update on a Phase Ib study of selatinib ditosilate tablets in patients with advanced breast cancer. The current status of the trial is not specified in the p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Selatinib Ditosilate Tablets (selatinib ditosilate)

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Advanced Breast Cancer | Phase 1 | Status: UNKNOWN